A study published in The New England Journal of Medicine looks at a new CRISPR gene therapy for children with a rare genetic disease. Dr Alena Pance, Senior Lecturer in Genetics, University of ...

A systematic review published in JAMA Psychiatry looks at weight loss drugs (GLP-1 receptor agonists) and mental health. Prof Stella Chan, Charlie Waller Chair in Evidence-based Psychological ...

“To delay this progress in order to align with slower EU processes would undermine our ability to deliver resilient, sustainable crops at a time when food security and climate resilience are more ...

Opportunities to deliver the best care possible are being missed. This is a real concern for the Royal College of Psychiatrists and their report makes practical recommendations for clinicians, ...

May 12, 2025 expert reaction to Government White Paper on immigration . Scientists comment on R&D elements of the Government’s White Paper on immigration. Sir Adrian Smith, Pres ...

“We have actually known that nanoparticles can enter the body through the lungs for over 20 years [1]. Many types of nanoparticles, including carbon, gold, silver, zinc oxide, titanium dioxide, and ...

A conference press release presented at the European Congress on Obesity (ECO) in Malaga looks at time-restricted eating (TRE) and weight loss in obese adults. Dr Adam Collins, Associate Professor of ...

Paper: ‘Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study’ by Yael Wolff Sagy et ...

A conference poster presented at the European Congress on Obesity (ECO) looks at weight loss drugs (GLP-1s) and reduced alcohol intake. Prof Kevin McConway, Emeritus Professor of Applied Statistics, ...

Results from a trial published in JAMA Network Open looks at online dialectical behavioural theory for emotion dysregulation in people with chronic pain. Dr Whitney Scott, Senior Lecturer in Clinical ...

A study published in JAMA Network Open looks at proximity to Golf Courses and the risk of Parkinson’s Disease.

“There are a number of hormones, mainly anabolic steroids that are classified as growth promoters. They were banned in the EU back in the 1980’s on the grounds they were a food safety risk. This has ...